Founder and Chairman
Computational chemistry
Omixon Inc
Hungary
Attila received his PhD in computational chemistry at the University of Calgary. Prior to founding Omixon, he worked as Associate Director and Head of Computational Chemistry at AstraZeneca, in Sweden. He received a corporate level IT award for innovative computational chemistry algorithm development at Novartis, where he was Head of Laboratory for Computational Chemistry. Before joining the pharmaceutical industry, he worked as a staff scientist at the Steacie Institute for Molecular Sciences. Dr. Bérces has published 50 peer-reviewed scientific research publications and presented over 30 papers at international conferences. In addition to science, Dr. Bérces studied R&D management and entrepreneurship at Chalmers University in Sweden, where he has been external advisor to seven MSc. students in the field of technology entrepreneurship.
I am passionate about new molecular diagnostics product development where the challenge involves the combination of IP strategy, licensing, market research,computational chemistry, competitive analysis and technology development.